Drug Trial Radar · NCT05701995
A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting
Last checked: Nov 20, 2026Latest source record: Jun 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
180
Actual
Start
Jan 31, 2023
Primary completion
Aug 23, 2024
Study completion May 29, 2025
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Jan 27, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effect of deucravacitinib on quality of life (QoL) in participants with plaque psoriasis in a community setting.
Conditions
- Psoriasis
Interventions
DeucravacitinibDrug
Specified dose on specified days.
PlaceboOther
Specified dose on specified days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Dermatology Life Quality Index (DLQI) Score of 0 or 1 at Week 16Time frame: At Week 16
Locations
38 sites in 2 countries. Site status is shown where the registry gives one.
Local Institution - 0006
Phoenix, Arizona
Local Institution - 0034
Scottsdale, Arizona
Local Institution - 0015
North Little Rock, Arkansas
Local Institution - 0004
Bakersfield, California
Local Institution - 0009
Sacramento, California
Local Institution - 0022
San Diego, California
Local Institution - 0030
Centennial, Colorado
Local Institution - 0024
Washington D.C., District of Columbia
Local Institution - 0027
Brandon, Florida
Local Institution - 0016
Coral Gables, Florida
Riverchase Dermatology
Pembroke Pines, Florida
Local Institution - 0037
Atlanta, Georgia
Local Institution - 0020
Snellville, Georgia
Local Institution - 0007
Rolling Meadows, Illinois
Local Institution - 0025
Skokie, Illinois
Local Institution - 0036
Springfield, Illinois
Local Institution - 0003
Baton Rouge, Louisiana
Local Institution - 0018
Rockville, Maryland
Local Institution - 0010
Auburn Hills, Michigan
Local Institution - 0002
Waterford, Michigan
Local Institution - 0017
Las Vegas, Nevada
Local Institution - 0035
Reno, Nevada
Local Institution - 0032
New York, New York
Local Institution - 0013
New York, New York
Local Institution - 0001
Rochester, New York
Local Institution - 0005
Bexley, Ohio
Local Institution - 0012
Mayfield Heights, Ohio
Local Institution - 0019
Charleston, South Carolina
Local Institution - 0029
Cypress, Texas
Local Institution - 0028
Frisco, Texas
Local Institution - 0008
South Jordan, Utah
Local Institution - 0033
Springville, Utah
Local Institution - 0021
Bellevue, Washington
Local Institution - 0031
Mill Creek, Washington
Local Institution - 0014
Spokane, Washington
Local Institution - 0040
Caguas, Puerto Rico
Local Institution - 0038
Carolina, Puerto Rico
Local Institution - 0039
San Juan, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.